Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

Modular Medical (NASDAQ: MODD) will participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference in Columbus, Ohio, from August 7-10, 2026.

Rhea-AI Summary

Modular Medical (NASDAQ: MODD) will participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference in Columbus, Ohio, from August 7-10, 2026. Management will host booth #1516 to showcase live demonstrations of its Pivot™ tubeless insulin patch pump ahead of an October launch in five U.S. markets.

Argus Aug 5 session 8 alerts

-6.94% close to close 0.8x rel. volume Open Argus

Details

News Market Reaction – MODD

-4.4% Trough in 6 hr 7 min

$11.41M Market Cap

On Aug 5, the day this news came out, MODD closed 6.94% below the previous close. Argus tracked a trough of -4.4% from its starting point during tracking. Our momentum scanner recorded 8 alerts for this stock that day.

Data tracked by StockTitan Argus for the Aug 5 session.

Market Context

On Aug 5, the day this news came out, the stock closed 6.9% below the previous close. MODD's July 16...

Analysis

On Aug 5, the day this news came out, the stock closed 6.9% below the previous close. MODD's July 16 pilot-collaboration announcement was followed by a -22.67% 24-hour move. A similarly weak response would contrast with the event's commercial focus, while the active S-3 shelf remains a financing and dilution risk.

Key Figures

Conference dates: August 7-10, 2026 Planned launch markets: five U.S. markets Pump operation: one-button operation +2 more

Conference dates

August 7-10, 2026

ADCES 2026 Annual Conference

Planned launch markets

five U.S. markets

October launch

Pump operation

one-button operation

Pivot tubeless insulin pump

Wear period

three-day wear period

Pivot tubeless patch pump

Conference booth

#1516

Greater Columbus Convention Center

Historical Context

5 past events · Latest: Jul 23

5 events

1. Jul 23

   Innovation council appointment

   24h Move

   +2.7%

   Formed Pivot Innovation Council and appointed Robert Gabbay as chairman

2. Jul 16

   Strategic pilot collaboration

   24h Move

   -22.7%

   Launched IMO Health pilot to identify potential pump candidates in electronic health records

3. Jul 15

   Payor research results

   24h Move

   -2.8%

   Reported positive payor receptivity toward Pivot reimbursement and partnership models

4. Jul 14

   Patient research results

   24h Move

   +8.0%

   Reported strong patient interest in simpler insulin pump therapy

5. Jul 01

   FDA submission

   24h Move

   +4.0%

   Submitted software enhancements for the Pivot tubeless insulin patch pump

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

tubeless patch pump, continuous subcutaneous insulin infusion, basal and bolus insulin delivery

3 terms

tubeless patch pump medical

"next-generation Pivot tubeless patch pump"

A tubeless patch pump is a small, adhesive wearable device that delivers medication (most commonly insulin) directly through the skin without external tubing, combining a reservoir, pump and controller in a single patch. Investors care because it represents a consumer-friendly alternative to traditional pumps that can boost device adoption, recurring supply sales and competitive differentiation, much like a wireless headset replacing a wired one for convenience and comfort.

continuous subcutaneous insulin infusion medical

"designed to provide continuous subcutaneous insulin infusion"

A therapy that uses a small wearable pump to deliver insulin under the skin through a thin tube, providing a steady baseline dose plus extra doses around meals to control blood sugar. Think of it like an automated drip and on-demand button combined, replacing multiple daily injections. It matters to investors because pump sales, consumable supplies, software updates, regulatory approvals and reimbursement policies drive revenue, adoption rates and competitive dynamics in the diabetes care market.

basal and bolus insulin delivery medical

"with both basal and bolus insulin delivery over a three-day wear period"

Basal and bolus insulin delivery describes two complementary ways insulin is given to people with diabetes: basal delivery provides a steady, background dose to control blood sugar between meals and overnight, like a drip that keeps a faucet trickle running; bolus delivery are larger, timed doses taken around meals to handle carbohydrate spikes, like turning the faucet on briefly. Investors care because products, devices, and drugs that target one or both delivery types address different customer needs, regulatory paths, and recurring-revenue models in the diabetes market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that management will host a booth at the Association of Diabetes Care & Education Specialists 2026 Annual Conference (the "Conference") in Columbus, Ohio, from August 7-10, 2026, where they will showcase the new Pivot tubeless insulin patch pump.

Conference attendees will have the opportunity to experience live demonstrations of the tubeless Pivot insulin pump and see firsthand how its intuitive, simplified design can expand access to insulin pump therapy. With one-button operation, tubeless freedom, and flexible wear that fits into everyday life, Pivot creates a compelling option for people who rely on daily insulin injections and may have never been offered pump therapy in the past. The Conference will provide an important opportunity for the team to engage diabetes care and education specialists, gather valuable feedback, and secure qualified leads, as they prepare for the October launch across five U.S. markets.

ADCES Conference Details:
Dates: August 7-10, 2026
Location: Greater Columbus Convention Center, Columbus, OH
Booth: #1516

To schedule a one-on-one meeting with Modular Medical's management team at the Conference, please email Patrick Pavlick at Patrick.pavlick@modular-medical.com or email KCSA Strategic Communications at ModularMedical@KCSA.com.

About the Pivot Tubeless Patch Pump

The Pivot™ tubeless patch pump is a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period. The system is intended to offer a practical and accessible pathway from multiple daily injections to insulin pump therapy for a broader population of people living with diabetes. For more information, visit www.pivotpump.com.

About Modular Medical, Inc.

Modular Medical, Inc. (NASDAQ:MODD) is a commercial-stage medical device company focused on the development of innovative insulin delivery technologies designed to simplify diabetes management and increase access to insulin pump therapy. The Company's Pivot™ tubeless patch pump has been developed to provide a user-friendly, flexible, and accessible approach to insulin delivery for people requiring intensive insulin therapy.

Forward-Looking Statements

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release, including but not limited to, the Company's ability to commence the commercial launch of its Pivot pump product across multiple U.S. markets in October 2026, successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, and general economic, and industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.

Pivot is a trademark of Modular Medical. All other trademarks mentioned herein are the property of their respective owners.

Company Contact:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
IR@modular-medical.com

Investor Relations Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
ModularMedical@KCSA.com

SOURCE: Modular Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Modular Medical (NASDAQ: MODD) attend the ADCES 2026 Annual Conference?

Modular Medical will attend the Association of Diabetes Care & Education Specialists 2026 Annual Conference from August 7-10, 2026. According to the company, the event takes place at the Greater Columbus Convention Center in Columbus, Ohio, with management hosting booth #1516.

What is Modular Medical showcasing at the ADCES 2026 Conference for MODD investors?

Modular Medical will showcase live demonstrations of its Pivot™ tubeless insulin patch pump at ADCES 2026. According to the company, the pump features one-button operation, tubeless wear, and a simplified design intended to expand access to insulin pump therapy for people using daily injections.

How can attendees schedule a meeting with Modular Medical management at ADCES 2026?

Attendees can request one-on-one meetings with Modular Medical management by emailing Patrick.pavlick@modular-medical.com or ModularMedical@KCSA.com. According to the company, these meetings will occur during the August 7-10, 2026 conference at the Greater Columbus Convention Center in Columbus, Ohio.

What is the Pivot tubeless patch pump highlighted by Modular Medical (MODD)?

The Pivot™ tubeless patch pump is a wearable insulin delivery platform providing continuous subcutaneous insulin with basal and bolus dosing over three days. According to Modular Medical, it is designed as an accessible pathway from multiple daily injections to insulin pump therapy for broader diabetes populations.

Why is the ADCES 2026 Conference important for Modular Medical and its Pivot pump?

The ADCES 2026 Conference gives Modular Medical a venue to demonstrate its Pivot pump, gather specialist feedback, and secure qualified leads. According to the company, these activities support preparation for the product’s planned October launch across five U.S. markets, potentially aiding commercial readiness.